Bespoke Extracts, Inc. (BSPK)
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Last price
- $0.00
- As of
Kresmion compiles this page from BSPK's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Bespoke Extracts, Inc. (BSPK): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-07-06.
See the full BSPK dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for BSPK on one page. Preview it with sample data, then open it live with a free account.
Preview the BSPK dossierActive events for BSPK
No recent events on BSPK in the last 180 days.
FREE, NO ACCOUNT
Every event on BSPK, as it fires
New filings, 13F moves and cross asset events on BSPK land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter.
Recent SEC filings, BSPK
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Going concern statement
BSPK's 10-Q filed Nov 12, 2025 states:
This raises substantial doubt about the Company's ability to continue as a going concern for a period of one year from the date of these financial statements.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on BSPK
BSPK against its peers
BSPK's operating margin of -89.0% ranks in the 71st percentile of 11 Drug Manufacturers - Specialty & Generic sub-industry peers, fiscal periods ending between 2024-12-31 and 2025-08-31.
| Metric | BSPK | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 1.1M USD | 575891 USD | 58 | 12 |
| Gross margin | 40.5% | 30.7% | 65 | 12 |
| Operating margin | -89.0% | -152.8% | 71 | 11 |
| Net margin | -92.8% | -171.7% | 63 | 14 |
Peers (15): OWPC, PNXP, KOAN, GCAN, GRPS, STEK, SXTC, AYRWF, CBDY, NPHC, SKYI, KAYS, IMCC, LVRLF, CPMD. Left out: XTXXF (period gap), FITY (no annual filing), PTPI (period gap), BNIGF (no annual filing), BTAIQ (period gap), NTRR (period gap), GREH (no annual filing), SFWJ (no annual filing), NASC (period gap), CBDL (no annual filing). Fiscal periods ending between 2024-12-31 and 2025-08-31. Every figure is one full fiscal year read from one annual filing (BSPK: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in BSPK on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on BSPK in the last 180 days.
Upstream: SEC EDGAR filings for BSPK
Kresmion, "Bespoke Extracts, Inc. (BSPK) institutional holdings and SEC filings", data as of 2026-07-06, https://kresmion.com/research/BSPK. Upstream data: SEC EDGAR filings for BSPK.
Link to this data (HTML):
<a href="https://kresmion.com/research/BSPK">Bespoke Extracts, Inc. (BSPK) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow BSPK on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to BSPK for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.